Dechra Pharmaceuticals PLC
DPH | IL
Overview
Corporate Details
- ISIN(s):
- US2434351043
- LEI:
- 213800J4UVB5OWG8VX82
- Country:
- United Kingdom
- Address:
- 24 CHESHIRE AVENUE, CW9 7UA NORTHWICH
- Website:
- https://www.dechra.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Dechra Pharmaceuticals PLC is a global veterinary pharmaceutical company that specializes in developing and marketing high-quality products for the treatment of animals. Founded in 1997, the company has grown to become a major player in the animal health industry, with a presence in over 45 countries around the world. Dechra Pharmaceuticals PLC is committed to improving the lives of animals through its innovative and effective products. The company's portfolio includes a wide range of products, including pharmaceuticals, vaccines, and nutritional supplements, for a variety of species, including dogs, cats, horses, and farm animals.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2024-01-23 17:41 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 23.4 KB | |
| 2024-01-18 16:14 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 21.7 KB | |
| 2024-01-18 11:11 |
Major Shareholding Notification
Holding(s) in Company
|
English | 26.8 KB | |
| 2024-01-17 15:01 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 21.9 KB | |
| 2024-01-17 13:01 |
Major Shareholding Notification
Holding(s) in Company
|
English | 51.4 KB | |
| 2024-01-17 13:00 |
Major Shareholding Notification
Holding(s) in Company
|
English | 54.9 KB | |
| 2024-01-17 12:16 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 29.1 KB | |
| 2024-01-17 09:15 |
Regulatory News Service
Cancellation of listing and admission to trading
|
English | 24.9 KB | |
| 2024-01-17 08:30 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 21.6 KB | |
| 2024-01-16 17:54 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 22.5 KB | |
| 2024-01-16 16:25 |
Takeover Announcement Report
Form 8.3 - Dechra Pharmaceuticals plc
|
English | 46.1 KB | |
| 2024-01-16 15:43 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 31.2 KB | |
| 2024-01-16 13:04 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 21.9 KB | |
| 2024-01-16 11:15 |
Takeover Announcement Report
Scheme of Arrangement becomes Effective
|
English | 45.8 KB | |
| 2024-01-16 10:00 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 29.7 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
MorphoSys AG | Germany | MOR | |
|
MPH Health Care | Germany | 93M1 | |
|
NATAC | Spain | NAT | |
|
Navamedic | Norway | NAVA | |
|
Newbury Pharmaceuticals AB | Sweden | NEWBRY | |
|
New Nordic Healthbrands AB | Sweden | NNH | |
|
Nicoccino Holding AB | Sweden | NICO | |
|
Nicox S.A. | France | COX | |
|
Novartis AG | Switzerland | NOVN | |
|
Nur Ink Innovations Ltd. | Israel | NURI |